Study of quality of life after completion of Re-Radiation treatment in Head and Neck Cancer patients
- Conditions
- Health Condition 1: null- patients receiving re-Irradiation (reRT).
- Registration Number
- CTRI/2018/03/012370
- Lead Sponsor
- il
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients must have recurrence/ second primary (SPN) at least 6 months after prior radiotherapy.
2. Patients should have histopathological proof for both the primary tumor and at recurrence / second cancer in the head and neck region.
3. Patients should have been treated with radical intent for primary tumor with appropriate radical doses of radiation.
4. Patients who are diagnosed with recurrent or second cancer for which the radiation portals will overlap the fields of previously irradiated region.
5. In the recurrent setting the intention of treatment is radical.
1.Patients having recurrence/ second primary (SPN) before completion of 6 months of prior radiotherapy.
2.Patients being treated with palliative intent in recurrent setting.
3.Radiation portals not overlapping the fields of previously irradiated region.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To document and evaluate change in quality of Life in patients receiving reRT for recurrence or second primary.Timepoint: After Completion of Radiation therapy
- Secondary Outcome Measures
Name Time Method 1.To evaluate changes in swallowing function, in patients receiving reRT. <br/ ><br>2.To establish dosimetric relationship between Dysphagia Aspiration Related Structures and severity of swallowing dysfunction in patients receiving Re-RT. <br/ ><br>3.To determine Incidence rate of acute and late toxicities associated with reRT. <br/ ><br>4.To determine DFS/ local control rates/ OS rates from date of diagnosis of second primary/ recurrence. <br/ ><br>5.To determine the pattern of disease progression post treatment in all patients.Timepoint: After Completion of Radiation therapy